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The intrinsic (gas-phase) stabilities of duplex, self-complementary oligonucleotides were
measured in a relative way by subjecting the duplex precursor ions to increasing amounts of
collision energy during the collisional-activated decomposition (CAD) events in an ion-trap
mass spectrometer. The results are displayed as a dissociation profile, an s-shaped curve that
shows the dependence of the relative abundance of the duplex on the applied collision energy.
The total number of charges, the total number of base pairs, and the location of the high
proton-affinity bases (i.e., G and C) are the main factors that affect the intrinsic stability of the
duplex oligonucleotides. If the charge state is the same, the stability, as measured as a
half-wave collision energy, E1/2, correlates well with the total number of H bonds for the
duplex. The intrinsic stabilities of noncovalent complexes between duplex oligonucleotide and
some DNA-binding drugs were also measured by using the newly developed method.
Although duplexes are stabilized in the gas phase when they bind to drug molecules,
correlations between gas-phase stabilities and the solution-binding affinities have not yet been
obtained. Complexes in which the drug is bound in the minor groove must be joined tightly
because they tend to dissociate in the gas phase by breaking covalent bonds of the
oligonucleotide to give base loss and small sequence-ion formation. Complexes in which the
drug is known to favor intercalation dissociate by breaking weak, noncovalent bonds to form
single-stranded oligonucleotides although cleavage of covalent bonds of the oligonucleotide
also occurs. (J Am Soc Mass Spectrom 2000, 11, 450–457) © 2000 American Society for Mass
Spectrometry
The specific noncovalent interaction of small or-ganic molecules with duplex DNA provides themolecular basis of many antitumor, antiviral, and
antibiotic drugs because compounds that bind to DNA
with high affinity can influence gene expression and,
therefore, affect cell proliferation and differentiation. A
wide variety of physical and chemical techniques, in-
cluding mass spectrometry, have been developed to
study the properties of these noncovalent complexes in
solution. The purpose is to obtain binding stoichiome-
try and specificity, and to elucidate the structure of the
complex.
Mass spectrometrists have taken an active role in
investigating noncovalent complexes involving
biopolymers [1–3], by taking advantage of the gentle
nature of the electrospray process, which allows intact
complexes with a wide range of associations to be
introduced into the gas phase [4]. To date, electrospray
ionization mass spectrometry (ESI-MS) has been suc-
cessfully used to investigate a wide variety of noncova-
lent interactions, including those of multimeric proteins
[5, 6], enzyme-inhibitor complexes [7, 8], oligonucleo-
tide duplexes [9–12] and tetramers [13], and noncova-
lent complexes of small organic molecules to single [14]
and double-stranded oligonucleotides [15–18].
ESI-MS can give binding stoichiometry for relatively
small amounts (picomoles) of material. Nonspecific
aggregation can also be reduced because studies can be
made at lower concentrations with ESI-MS than with
other spectroscopic techniques. Moreover, binding af-
finity, specificity, and structure can be determined with
ESI-MS and tandem mass spectrometry.
Address reprint requests to Michael L. Gross, Department of Chemistry,
Washington University, St. Louis, MO 63130. E-mail: mgross@
wuchem.wustl.edu
© 2000 American Society for Mass Spectrometry. Published by Elsevier Science Inc. Received October 8, 1999
1044-0305/00/$20.00 Revised December 29, 1999
PII S1044-0305(00)00095-7 Accepted December 29, 1999
Intrinsic (gas-phase) properties of duplex oligonucle-
otides and their corresponding noncovalent complexes
with small organic molecules (e.g., drugs), however,
have not been established systematically, although the
pioneering work of Smith’s group [1, 16] shows that
such measurements are in the offing. Schnier et al. [19]
reported the dissociation kinetics of a series of small
complementary and noncomplementary DNA duplexes
by using blackbody infrared radiative dissociation in
the trap of a Fourier transform mass spectrometer. They
found that Watson–Crick base pairing can exist in the
complete absence of solvent for duplex oligonucleotides
as small as 7-mers.
In this article, we describe a methodology based on
ESI and ion-trap mass spectrometry to study the intrin-
sic properties of duplex oligodeoxynucleotides and
their corresponding noncovalent complexes with drugs.
Our goal is threefold: to understand the fragmentation
pathways, to establish binding modes and intrinsic
stabilities, and to develop an easily accessible method
by using readily available instrumentation. We also
intend to compare and correlate the gas-phase stability
with those in solution. By doing so, we expect to gain
insight into solvent effects and understand the driving
force for noncovalent interactions in the gas phase.
The methodology we developed to study the gas-
phase stability of noncovalent associations is to monitor
the dissociation profiles of the noncovalent complexes
as a function of collision energy. Unlike guided-ion
beam mass spectrometry, where quantitative thermo-
dynamic and kinetic information about ionic transition
metal species have been obtained by threshold mea-
surements of collisionally activated dissociations (CAD)
[20–22], our methodology cannot provide absolute en-
ergetics about the bond energies of noncovalent associ-
ations because the kinetic energy is not well defined
during the collisional event in the ion trap. Rather, we
obtain relative energies of large complexes by using a
widely used mass spectrometer. Furthermore, we de-
fine a half-wave collision energy (E1/2), which corre-
sponds to the collision energy (in percentage of the
maximum “tickling” voltage) at which the relative
abundance (in fraction of total ion current) of the
precursor ion is 0.5. Our hypothesis is that gas-phase
stabilities of noncovalent complexes can be ranked in
relative terms by their E1/2’s. Similar strategy has been
applied to study the interaction of a protein and its
inhibitors in a Fourier transform ion cyclotron reso-
nance mass spectrometer [1].
Experimental
Materials
All oligodeoxynucleotides were synthesized and puri-
fied (on the 0.2-mmol scale) by the Nucleic Acid Chem-
istry Laboratory at Washington University and were
used without further purification. Group-I drugs (dis-
tamycin, Hoechst 33258, Hoechst 33342, berenil, and
actinomycin D) were purchased from Sigma Chemical
(St. Louis, MO), and group-II drugs (porphyrin
H2TMpyP-4 and metalloporphyrin CuTMpyP-4,
FeTMpyP-4, and MnTMpyP-4) were obtained from
Porphyrin Products (Logan, UT). Drug 10
([Ru(II)12S4dppz]C12) was donated by Professor
Graca Santana Marques (Department of Chemistry,
University of Aveiro, Portugal).
Sample Preparation
Stock solutions of 10 mL of 5-mM, self-complementary
oligodeoxynucleotide were annealed in 50 mL of 1-M
ammonium acetate by heating to 85 °C for 10 min and
cooling to room temperature slowly (over 2 to 3 h). For
drug-binding studies, 10 mL of the solution containing
the annealed duplex oligonucleotides was mixed with
10 mL of 0.8-mM aqueous solution of the drugs to form
the complex. Each 20-mL solution containing the com-
plex was diluted with spray solvent (50/50 V/V
MeOH/100 mM ammonium acetate) to 100 mL for mass
spectrometry analysis.
ESI-MS with an Ion-Trap Mass Spectrometer
Mass spectra of ESI-produced negative ions were ob-
tained with the Finnigan LCQ mass spectrometer (San
Jose, CA). The solutions were infused directly at 3
mL/min into the mass spectrometer. The spray voltage
was 4.0 kV. The capillary temperature was 100 °C for
the noncovalent complexes of duplex oligonucleotides
of eight base pairs or less; otherwise the temperature
was 150 °C. The N2 bath-gas flow was increased by
approximately 1.5 times over that normally used for
electrospray at 200 °C to ensure efficient desolvation.
The analyzer was operated at a background pressure of
2 3 1025 torr, as measured by a remote ion gauge. In all
experiments, helium was introduced, as was usual, to
an estimated pressure of 1 mtorr for improving the ion
trapping efficiency. The background helium gas also
served as collision gas during the CAD event. The
noncovalent complexes were isolated in the ion trap
and activated by using increasing collision energies (in
1% increments from 12% to 18% of the maximum
available from a 5-V tickle voltage) to obtain collision-
energy-dissociation profiles. The scan rate for product
ions was 5000 u/min. Data from approximately 10
scans were collected and analyzed with both the instru-
ment software and the ICIS software provided by the
manufacturer.
Results and Discussion
Duplex Oligonucleotides in the Gas Phase
We chose self-complementary oligonucleotides for this
study because less sample preparation is involved, and
their mass spectra are simple to interpret. Peak assign-
ment, however, is sometimes problematic because sin-
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gle- and double-stranded oligonucleotides with even
number of charges will have the same mass-to-charge
ratio. Although one could assign those peaks based on
the incremental mass-to-charge ratio difference of Na-
adduct ions [16], it is not easy to make an unambiguous
assignment when both [single-stranded]n2 and [dou-
ble-stranded]2n2 ions are present. To avoid any uncer-
tainty about ion identity, we chose to activate by
collisions only duplex ions with odd-numbered charge
states and to study their fragmentation pathways and
gas-phase stabilities. We assume that conclusions
drawn about complexes with odd-numbered charge
states apply to those with even charge states.
Fragmentation pathways of double-stranded oligonucleotides.
To generate sufficiently intense signals for duplex pre-
cursor ions, the ESI interface conditions were opti-
mized, and 50-mM ammonium acetate buffer was used
as the spray solvent to maintain adequate ionic strength
to see the complexes [23]. The product-ion mass spectra
of a duplex [6-mer]32 (panel A of Figure 1) and a duplex
[12-mer]52 (panel B of Figure 1) were produced upon
low-energy collisional activation and show that these
shorter duplexes undergo dissociations in which non-
covalent bonds are broken to give single-stranded oli-
gonucleotides. Longer oligonucleotides, however, un-
dergo extensive cleavages of covalent bonds in addition
to breakage of noncovalent bonds. These phenomena
were observed for related complexes in other studies [1,
24]. The usual explanation is that larger duplexes are
stabilized in the gas phase by H bonding and p stack-
ing. Therefore, it is not surprising that dissociation of
two strands bonded via multiple weak interactions will
ultimately require more energy than cleavage of one
covalent bond.
We studied the fragmentation patterns for a series of
self-complementary 6-mers that have different se-
quences, ranging from AT-rich to GC-rich sequences.
The propensity for cleavages of covalent bonds in-
creases as we varied the sequences from AT rich to GC
rich. At the same collision energy (15% of the maximum
tickling voltage, which is 5 eV) that was used to obtain
the product-ion mass spectrum for the triply charged
duplex ATATAT (Figure 1A), [d(GCGCGC)2]
32 gave
quite abundant product ions by cleavage of covalent
bonds (spectrum not shown here). For example, losses
of the bases G and C and the loss of an a1 neutral from
the duplex give product ions of relative abundances
(RA) 40%, 40%, and 34%, respectively. The dissociation
of noncovalent bonds for duplex 6-mer GCGCGC gives
product ions of doubly charged singled-stranded 6-mer
(RA 5 15%). We noticed that even at a collision energy
that corresponds to 20% of the maximum tickling
voltage, [d(ATATAT)2]
32 did not undergo any cleavage
of covalent bonds (RA , 5%).
The differences in the fragmentation patterns for
AT-rich and GC-rich small duplexes are probably due
to two factors. First, there are three H bonds between a
GC base pair, whereas there are only two between an
AT base pair. Second, the proton affinity of G is higher
than that of T. It is established for single-stranded
oligonucleotides that protonation of the base initiates
the base loss and causes the subsequent phosphate
backbone cleavages [25]. Therefore, for the GC-rich
duplexes, loss of a base that has a large PA preempts
destruction of the H bonds and the dissociation of
noncovalent bonds. For the AT-rich duplexes, the dis-
sociation of noncovalent bonds is more facile than for
GC-rich duplexes because the bases have relatively low
PAs and the number of H bonds between the two
strands is small.
Comparing Figure 1A with Figure 1B, we find that
large duplexes tend to undergo covalent bond cleav-
ages, whereas small duplexes dissociate noncovalently.
For a duplex 12-mer (Figure 1B), cleavages of both
covalent bonds and noncovalent bonds occur. Loss of
the terminal bases (G and C) and the internal bases (loss
of A from the duplex) also take place. The loss of T from
the middle of the double-stranded oligonucleotide does
not occur probably because T has the lowest proton
affinity among the four nucleobases [25]. We also found
that, upon activation, the duplex [12-mer]52 precursor
ion breaks covalent bonds to form, by expulsion of
small sequence ions (for example, w1, a2, d2, and a4),
four product ions, indicating that terminal “unzipping”
of the large duplex may happen in the gas phase [16].
The singly charged sequence ions were not observed in
Figure 1. Negative-ion low-energy CAD spectra of triply
charged A d(ATATAT)2 and B d(CGCGAATTCGCG)2.
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the spectrum because the low-mass cutoff of the instru-
ment is too high.
Comparing Figure 1A with Figure 1B, we conclude
that large duplexes tend to undergo covalent bond
cleavages while small duplexes tend to dissociate non-
covalently.
Dissociation profiles of gas-phase oligodeoxynucleotides.
The gas-phase stabilities of self-complementary duplex
oligonucleotides were studied by subjecting the duplex
precursor ions to increasing collision energies in an
ion-trap instrument and monitoring the resulting rela-
tive abundance of the duplex as a function of the
collision energy. Plots of the collision energy/dissocia-
tion profiles of duplex oligonucleotides of different
length, sequence, and charge states resemble the solu-
tion-phase melting curve of double-stranded DNA, and
so we lightly refer to it as a gas-phase “melting” curve.
We also define a half-wave collision energy (E1/2) that
corresponds to the collision energy (in percentage of the
maximum tickling voltage) at which the relative abun-
dance (in fraction of total ion current) of the duplex
precursor ion is 0.5. Therefore, E1/2 is the analog of a
melting temperature (TM) in a DNA melting curve. The
larger the E1/2 value, the more stable the duplex in the
gas phase.
The activation process in the ion trap has an m/z
dependence. Therefore, we carefully chose the drugs so
that the complexes that we activated in the gas phase
have similar m/z values (the molecular weights of the
porphyrins in group II vary from 678 to 740).
From Figure 2, we notice that the charge state of
duplex in the gas phase bears an important influence on
the dissociation profile. As the charge of the duplex
increases from 32 (Figure 2A) to 52 (Figure 2B), the
E1/2 values decrease significantly. The observed lower
gas-phase stability with higher charge state is attributed
to the stronger coulombic repulsion between the two
strands, and that facilitates dissociation of the duplex.
For duplexes that have the same charge state, larger
duplexes have greater gas-phase stability because the
additional base pairing and p stacking provide extra
stabilization. For example, in Figure 2A, duplex 8-mers
(in filled circles and squares) have larger E1/2 values
than those of duplex 6-mers (in open circles and
squares). In Figure 2B, duplex 12-mers (in filled circles
and squares) have larger E1/2 values than those of
duplex 10-mers (in open circles and squares).
For duplexes that have the same length and charge
state, the base composition determines the gas-phase
stability. We found that the GC-rich duplexes are more
stable than the AT rich. Each GC base pair is bound by
three H bonds compared to only two per AT base pair.
Illustrative data, in Figure 2A, show the increasing E1/2
values for 6-mers starting with AT rich [d(ATATAT)2]
to GC rich [d(ATGCAT)2 and d(AGCGCT)2]. This trend
is also seen for the data in Figure 2B (AT rich 10-mers
and 12-mers are less stable than the corresponding
GC-rich species). Taking a closer look at the isomeric
duplexes (same base composition), we find that the
position of the high proton-affinity base (G and C) also
impacts the gas-phase stability. When the high proton-
affinity bases are located at the terminal positions (59 or
39), the duplex shows a smaller E1/2 (is less stable in the
gas phase) than does the isomeric duplex in which the
high proton-affinity base is in the middle position. As
seen in Figure 2A, for example, d(ATGCAT)2 is more
stable than d(GAATTC)2, and d(TATGCATA)2 is more
stable than d(CAAATTTG)2.
The fragmentation mechanisms of single-stranded
oligonucleotides [25] show that protonation of the
nucleobase initiates the base loss, leading to subsequent
backbone cleavages. Assuming that the duplex dissoci-
ation in the gas phase starts with terminal unzipping of
the two strands [16], we conclude that when high
proton-affinity bases are at the terminal positions of a
duplex, loss of a high PA base and subsequent unzip-
ping will occur, causing the stability of the duplex in the
gas phase to decrease. On the other hand, when a low
PA base (T) is located at the terminal position, terminal
unzipping is difficult, and more energy is required to
pull apart the duplex.
Gas-phase stability and H bonding. We investigated the
relationship between the number of H bonds in a
duplex and the gas-phase stability of that duplex as
reflected by the E1/2 values. Figure 3 shows that a linear
relationship exists between the numbers of H bonds in
a series of self-complementary duplexes and the mea-
sured E1/2 values. For DNA melting curves, more H
Figure 2. (A) Dissociation profiles of a series duplex [6-mers]32
and [8-mers]32. (B) Dissociation profiles of a series duplex [10-
mers]52 and [12-mers]52.
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bonds (base pairs) result in higher TM (higher stability)
of the duplex. Although the prospects of obtaining
information regarding solution stability directly from
the corresponding gas-phase measurements are not yet
established, the solution properties for this series of
oligonucleotides appear to be preserved in the gas
phase.
Duplex Oligonucleotides and Drug Complexes in
the Gas Phase
The binding mode of drugs to DNA is the foundation
for understanding the molecular basis of DNA/drug
binding. We recently reported an assay method for
determining the sequence selectivity of various drugs
(Schemes 1 and 2) [23] and we found that the relative
extent of binding can be used as an “indicator” to assess
the mode of binding. We now introduce these nonco-
valent complexes of duplex oligonucleotides with var-
ious drugs into the gas phase, investigate their gas-
phase stabilities by studying their CAD, and compare
the stabilities with those in solution.
Fragmentation pathways of the noncovalent complexes.
Distamycin (drug 1) is an oligopeptide antibiotic that
inhibits the binding of RNA polymerase, and hence
transcription in vitro [26]. The drug acts by binding to
the minor groove of AT-rich regions of DNA with a
binding constant in the range of 107 to 108 M21 [27],
depending on the size and sequence of the oligomer.
Actinomycin D (drug 5) has very potent antitumor
activity and has been used clinically as a chemothera-
peutic agent. Its mechanism of action at the molecular
level has been attributed to its inhibition of DNA-
directed RNA synthesis, whereas its phenoxazone chro-
mophore intercalates at the GC sites of duplex DNA [28,
29].
Two different noncovalent complexes with very dif-
ferent binding modes fragment differently (Figure 4). A
duplex 12-mer noncovalently bound to the minor-
groove binder, distamycin, undergoes two fragmenta-
Figure 3. Correlation of the measured E1/2 values and number of
H bonds in the duplexes.
Scheme 1. Structures of drugs. 1: Distamycin, 2: Hoechst 33258,
3: Hoechst 33342, 4: Berenil, 5: Actinomycin D.
Scheme 2. Structures of drugs (continue). 6: Porphyrin, 7:
Cu-porphyrin, 8: Fe-porphyrin, 9: Mn-porphyrin, 10:
[Ru(II)12S4dppz]Cl2.
Figure 4. Negative-ion low-energy CAD spectra of quintuply
charged noncovalent complexes A d(CGCGAATTCGCG)2 with
distamycin and B d(CGCGAATTCGCG)2 with actinomycin.
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tions (Figure 4A); one involves cleavage of noncovalent
bonds to give a single-stranded 12-mer and a single-
stranded 12-mer bound to the drug. The other fragmen-
tation is of covalent bonds whereby the core structure of
the complex remains ostensibly intact, and some of the
terminal portions of the duplex are expelled. Compared
with the product-ion spectrum of the duplex 12-mer
itself (Figure 1B), that of the noncovalent complex with
the drug shows there is clear preference for cleavages of
covalent than noncovalent bonds. Note the change of
the base peak of the [single-stranded 12-mer]32 (Figure
1B) to loss of G (Figure 4A) upon the binding of
minor-groove binder distamycin to the duplex 12-mer.
This is probably because the minor-groove binder dis-
tamycin binds in the –AATT– region of the duplex and
provides extra stabilization to hold together the two
strands, repressing dissociation of noncovalent bonds
by neutralizing the negative surface potential in the
minor groove of AT-rich region [30]. Local unzipping at
the terminal portions of the duplex makes it possible to
observe some small sequence-ion losses from either
strand; for example, loss of singly charged a2, a4, and
(d2 1 G) ions from the complex or losses of the terminal
bases G and C. As observed for the duplex 12-mer itself,
base A is lost from the middle of the duplex, indicating
that local unwinding and base loss from the duplex do
not change significantly the duplex conformation in the
gas phase.
We also studied the fragmentation patterns of com-
plexes binding Hoechst 33258 (D2), Hoechst 33342 (D3),
and berenil (D4) with the same duplex 12-mer. The
complexes undergo similar fragmentation as with dis-
tamycin (D1) (data are not shown here), indicating that
the drugs bind in the minor groove of the AT region.
The same duplex 12-mer when noncovalently bound to
intercalator actinomycin D, also undergoes two frag-
mentations. The CAD spectrum (Figure 4B) was ob-
tained at the same collision energy (CE 5 15% of the
maximum tickling voltage) as that used to obtain Figure
4A. One fragmentation is dissociation of noncovalent
bonds to give the single-stranded 12-mer, with and
without the drug molecule. The other is breakage of
covalent bonds to allow losses of the high PA bases
from the complex. Unlike the complex showing minor-
groove binding (Figure 4A), that bound via intercala-
tion undergoes dissociation of noncovalent bonds {note
that the base peak in Figure 4B is [single-stranded
12-mer]22 rather than [Complex 2 G]52 (base peak in
Figure 4A)}. Reduction of the interaction surface for the
duplex, owing to intercalation, and concomitant reduc-
tion of the bonding of the two strands account for this
phenomenon.
To probe the binding mode more deeply, we studied
another pair of drug-DNA duplex complexes. In solu-
tion, the cationic porphyrin H2TMpyP (drug 6) binds
with both AT- and GC-rich sequences, whereas
[Ru(II)12S4dppz]Cl2 (drug 10) prefers to bind to GC-rich
sequences [23]. The sequence selectivity suggests that
D6 binds to duplex DNA through either minor-groove
binding mode or intercalation. To gain more informa-
tion about the binding, we collisionally activated the
noncovalent complex of D6 and the AT-rich, 6-mer
duplex. The resulting fragmentation (Figure 5A) is
characteristic of complexes binding in the minor
groove; that is, complexes that fragment preferentially
by cleavages of covalent bonds.
Although D10 strongly binds to the duplex with
GC-rich sequences, it does interact with the duplex
possessing an AT-rich sequence. To investigate further
the nature of this binding, we collisionally activated the
noncovalent complex of D10 and duplex ATATAT
(Figure 5B). The complex dissociates exclusively via
cleavages of noncovalent bonds, suggesting that D10
does not bind in the minor groove of a gas-phase
duplex. Rather, it may bind outside the duplex through
electrostatic interactions with the phosphate groups.
Dissociation profiles. The gas-phase stabilities of non-
covalent complexes formed by different drugs (dista-
mycin, actinomycin, and Mn-porphyrin) with d(ATG-
CAT)2 were evaluated by studying the collision-energy
dependence of the complex bearing three negative
charges (Figure 6). All three drugs stabilize duplex
oligonucleotides in the gas phase. Intercalator actino-
mycin D stabilizes the duplex more than the minor-
groove binder distamycin. Although actinomycin D
and distamycin have comparable binding affinities (107
to 108 M21) in solution [31], the difference in their
Figure 5. Negative-ion low-energy CAD spectra of 32 noncova-
lent complexes A d(ATATAT)2 with porphyrin and B
d(ATATAT)2 with drug 10.
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gas-phase stabilities may be due to two factors. First,
the molecular weight of actinomycin is 773 u greater
than that of distamycin, allowing more opportunities
for interactions that decrease dissociation. Second, acti-
nomycin D binds to duplex DNA by intercalating its
phenoxazone chromophore with the GC site [31], and
its two pentacyclic peptide chains reside in the nearby
minor groove. Therefore, actinomycin D provides sta-
bilization by both binding at the minor groove and by
intercalating. This additional stabilization becomes
more important when the solvent molecules and/or the
counterions are removed during the ESI process.
Drug Mn(III)TMpyP has a binding affinity of ap-
proximately 106 M21 in solution [32–34], but it offers the
greatest stabilizing influence in the gas phase. This
observation is not surprising because the electrostatic
interaction between the duplex and the Mn(III)TMpyP
should be much stronger than that for the other two
drugs. Because we activated the 32 precursor ions, the
electrostatic interactions can be represented as duplex
(27)/Mn(III)TMpyP (14), whereas for distamycin and
actinomycin, the interaction is duplex (24)/drug (11).
This illustrates the difficulty of correlating gas-phase
and solution stabilities over a broad range.
We also investigated the gas-phase stabilities of
other drug/duplex DNA complexes. Drugs 1, 2, 3, and
4 give similar E1/2 values for their complexes with
d(GCGAAATTTCGC)2 (data not shown) but different
than drugs 6, 7, 8, and 9, which themselves give similar
E1/2 values when their complexes with d(ATATAT)2
are activated (data not shown here). The similarity in
the dissociation profiles suggests that the noncovalent
complexes adopt very similar gas-phase conformations
when their binding modes are the same.
The binding of a second distamycin ligand to duplex
DNA can further stabilize the duplex both in solution
and in the gas phase [16]. Figure 7 shows the gas-phase
dissociation profiles of d(GCGCGC)2 with one and with
two Cu(II)TMpyP ligands. The complexes are more
stable when two ligands are bound. The observed
difference in gas-phase stability may be due to addi-
tional stacking interactions between the two ligands
and/or to neutralization of the negative charges on the
duplex.
The stepwise dissociation processes of the Hoechst
33342 complex were monitored and summarized in
Figure 8. When a duplex with one ligand was activated,
it dissociates to give back the duplex (Figure 8A). When
a duplex with three ligands was activated, it undergoes
sequential ligand loss to give (duplex 1 2 ligands),
(duplex 1 1 ligand) and the duplex itself (Figure 8B).
Conclusions
Dissociation profiles can be obtained rapidly to give a
qualitative picture of the gas-phase stabilities of nonco-
valent complexes. Although quantitative bond energies
cannot be obtained at this stage with the ion trap mass
Figure 6. Dissociation profiles of d(ATGCAT)2
32 and its nonco-
valent triply charged complexes with distamycin, actinomycin,
and Mn-porphyrin. Figure 7. Dissociation profiles of d(GCGCGC)2
32 with one and
two Cu-porphyrin ligands.
Figure 8. (A) Dissociation profiles of [d(CGCGAATTCGCG)2 1
Hoechst 33342]52. (B) Dissociation profiles of [d(CGCGAAT-
TCGCG)2 1 3 Hoechst 33342]
52.
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spectrometer, the method can provide reproducible
relative gas-phase stabilities with a low-cost, widely
available instrument. The binding mode and details on
other aspects of binding can be determined by investi-
gating the product-ion spectra of the noncovalent com-
plexes in the gas phase.
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